Clinical Trial Update: Prospective Multicenter Real-world Study of Surufatinib in Patients With Advanced Neuroendocrine Neoplasms [Phase 4]

View source ↗

Summary

A Phase 4 prospective real-world trial of surufatinib in patients with advanced neuroendocrine tumors or neuroendocrine neoplasms is currently recruiting at mul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroendocrine Neoplasm
• Neuroendocrine Tumor

Drugs mentioned

• Surufatinib (Surufatinib)

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Neuroendocrine Tumors, Neuroendocrine Neoplasms | Phase 4 | Status: RECRUITING